The Ishares Nasdaq Biotechnology E (NYSE: IBB) update and the technical summary table below can help you manage risk and optimize returns. We have day, swing, and longer-term trading plans for IBB, and 1300 other stocks too, updated in real time for our trial subscribers. The data below is a snapshot, but updates are available now.
Review the Trading Plans:
Long Term Trading Plans for IBB
January 12, 2019, 7:00 pm ET
The Technical Summary and Trading Plans for IBB help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this IBB Report.
IBB - (Long) Support Plan
The technical summary data tells us to buy IBB near 107.47 with an upside target of 122.30. This data also tells us to set a stop loss @ 107.21 to protect against excessive loss in case the stock begins to move against the trade. 107.47 is the first level of support below 109.01 , and by rule, any test of support is a buy signal. In this case, support 107.47 is being tested, a buy signal would exist.
IBB - (Short) Resistance Plan
The technical summary data is suggesting a short of IBB as it gets near 122.30 with a downside target of 107.47. We should have a stop loss in place at 122.56 though. 122.30 is the first level of resistance above 109.01, and by rule, any test of resistance is a short signal. In this case, if resistance 122.30 is being tested, a short signal would exist.